Skip to content
MedsAcross

Medicine

Montelukast 10 mg tablet

Montelukast · Oral
Available on requestPrescription onlyUS FDAGeneric name

Montelukast 10 mg tablet is a generic prescription medicine for oral use, made by 30 labelers, with its source record on the US FDA register. It is available on request for export supply from India to licensed hospitals, importers and physicians.

Availability

Available on request

Export supply from India to licensed buyers

Typical lead time

On request

Counted from payment and complete documents

Shipping

Ambient

Store montelukast sodium 10-mg film-coated tablets at 20° to 25°C (68° to…

Key facts

Active ingredient (INN)
Montelukast
Brand
Sold under the generic name
Strength
10 mg
Dosage form
Tablet
Route
Oral
Packs
30 tablets, 90 tablets, 1000 tablets and 124 more
Manufacturers
Aurobindo PharmaIndiaCamber PharmaceuticalsIndiaDr. Reddy's LaboratoriesIndiaMacleods PharmaceuticalsIndiaTorrent PharmaceuticalsIndiaUnichem LaboratoriesIndiaAccord HealthcareIndiaAjanta PharmaIndiaRising Pharma HoldingsAmneal Pharmaceuticals30 labelers on the register
Origin register
US FDA, United States
Storage
Store montelukast sodium 10-mg film-coated tablets at 20° to 25°C (68° to 77°F), excursions permitted to 15° to 30°C (59° to 86°F). Storage for Bulk Bottles Store bottles of 500 montelukast sodium 10-mg filmcoated tablets at 20° to 25°C (68° to 77°F), excursions permitted to 15° to 30°C (59° to 86°F). Protect from moisture and light. Store in original package. Store in original container.
Cold chain
Not required on record
Prescription status
Prescription only
Controlled substance
Not recorded as controlled
ATC code
R03DC03 Montelukast
HS code (indicative)
3004.90Indicative only. Your customs broker confirms the final tariff code.
Marketing category
marketed
Marketed since
28 February 2012
Identifiers
RxCUI 200224, 242438, 311759 +1DailyMed set ID 4c411d3e-47b6-481b-b846-419ed4cbb947, 3d4451a9-d73d-b9de-68ec-853bfeff6e4b, 901385e5-7384-4c28-a36a-7dd84c36f5fd +37NDC 68001-361, 55111-725, 63187-692 +37Application ANDA203366, ANDA201582, ANDA203432 +9

Record updated 12 November 2026

Documents available

Documents that can be provided with this medicine. Your regulator may ask for more, and the quote lists the full set.

No document list is recorded for this medicine yet. Tell us which documents your regulator needs (for example a CoA, COPP or GMP certificate) when you request a quote.

Packs

A sample of 40 packs from 30 labelers. The register lists 127 packs for this generic presentation, and we confirm the exact pack on the quote.

PackCodeLabelerMarketed since
30 tablet, film coated in 1 bottle16729-119-10Accord HealthcareIndia11 June 2013
90 tablet, film coated in 1 bottle16729-119-15Accord HealthcareIndia11 April 2013
1000 tablet, film coated in 1 bottle16729-119-17Accord HealthcareIndia20 November 2014
30 tablet, coated in 1 bottle27241-018-03Ajanta PharmaIndia13 August 2015
90 tablet, coated in 1 bottle27241-018-09Ajanta PharmaIndia13 August 2015
1000 tablet, coated in 1 bottle27241-018-90Ajanta PharmaIndia13 August 2015
10 blister pack in 1 carton / 10 tablet, film coated in 1 blister pack65862-574-10Aurobindo PharmaIndia3 August 2012
10000 tablet, film coated in 1 bottle65862-574-19Aurobindo PharmaIndia3 August 2012
30 tablet, film coated in 1 bottle65862-574-30Aurobindo PharmaIndia3 August 2012
6000 tablet, film coated in 1 bottle65862-574-66Aurobindo PharmaIndia31 August 2026
90 tablet, film coated in 1 bottle65862-574-90Aurobindo PharmaIndia3 August 2012
100 tablet, film coated in 1 bottle31722-726-01Camber PharmaceuticalsIndia10 September 2014
1000 tablet, film coated in 1 bottle31722-726-10Camber PharmaceuticalsIndia10 September 2014
30 tablet, film coated in 1 bottle31722-726-30Camber PharmaceuticalsIndia10 September 2014
10 blister pack in 1 carton / 10 tablet, film coated in 1 blister pack31722-726-32Camber PharmaceuticalsIndia10 September 2014
90 tablet, film coated in 1 bottle31722-726-90Camber PharmaceuticalsIndia10 September 2014
100 tablet, coated in 1 bottle55111-725-01Dr. Reddy's LaboratoriesIndia6 August 2012
1000 tablet, coated in 1 bottle55111-725-10Dr. Reddy's LaboratoriesIndia6 August 2012
30 tablet, coated in 1 bottle55111-725-30Dr. Reddy's LaboratoriesIndia6 August 2012
10 blister pack in 1 carton / 10 tablet, coated in 1 blister pack55111-725-78Dr. Reddy's LaboratoriesIndia6 August 2012
90 tablet, coated in 1 bottle55111-725-90Dr. Reddy's LaboratoriesIndia6 August 2012
30 tablet in 1 bottle33342-102-07Macleods PharmaceuticalsIndia11 September 2014
90 tablet in 1 bottle33342-102-10Macleods PharmaceuticalsIndia11 September 2014
100 tablet in 1 blister pack33342-102-12Macleods PharmaceuticalsIndia11 September 2014
500 tablet in 1 bottle33342-102-15Macleods PharmaceuticalsIndia11 September 2014
90 tablet in 1 blister pack33342-102-39Macleods PharmaceuticalsIndia11 September 2014
500 tablet in 1 bottle13668-081-05Torrent PharmaceuticalsIndia3 August 2012
30 tablet in 1 bottle13668-081-30Torrent PharmaceuticalsIndia3 August 2012
3200 tablet in 1 bottle13668-081-32Torrent PharmaceuticalsIndia3 August 2012
100 tablet in 1 carton13668-081-74Torrent PharmaceuticalsIndia3 August 2012
90 tablet in 1 bottle13668-081-90Torrent PharmaceuticalsIndia3 August 2012
100 tablet, film coated in 1 bottle, plastic29300-220-01Unichem LaboratoriesIndia1 January 2016
1000 tablet, film coated in 1 bottle, plastic29300-220-10Unichem LaboratoriesIndia1 January 2016
30 tablet, film coated in 1 bottle, plastic29300-220-13Unichem LaboratoriesIndia1 January 2016
90 tablet, film coated in 1 bottle, plastic29300-220-19Unichem LaboratoriesIndia1 January 2016
90 tablet in 1 bottle16571-100-09Rising Pharma Holdings1 June 2023
1000 tablet in 1 bottle16571-100-10Rising Pharma Holdings1 June 2023
30 tablet, film coated in 1 bottle57237-255-30Rising Pharma Holdings3 August 2012
90 tablet, film coated in 1 bottle57237-255-90Rising Pharma Holdings3 August 2012
30 tablet in 1 bottle65162-732-03Amneal Pharmaceuticals31 July 2013

Status by register

Where this medicine is registered, from the source record and the regulator data we hold. Ask us about a country that is not listed.

RegisterStatusSource
US FDAListed, marketedSource record for this pageChecked 12 November 2026
US FDAFirst approved 20 February 1998Drugs@FDA
EU (EMA)Not recorded—
India (CDSCO)Not yet confirmed against CDSCO approval lists—
United StatesRegisteredUS FDA (NDC directory, openFDA)Checked 12 November 2026

Import route

Pick the destination country to see the legal import route, who applies and typical timelines, from our import guide for that country.

Import guides are available for 25 countries. Pick one to see its route summary.

BrazilColombiaEgyptEthiopiaGhanaIraqKazakhstanKenyaAll import guides

Alternatives

Other makers and brands of Montelukast 10 mg tablet.

Compare 1

Other strengths and forms of Montelukast

Clinical summary

Montelukast is a leukotriene receptor antagonist indicated for prophylaxis and chronic treatment of asthma in patients 12 months of age and older, among other approved uses. MedsAcross supplies Montelukast for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.

Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review

Read about Montelukast

For healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.

Data sources

Need Montelukast 10 mg tablet for your hospital or patient?

Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.